www.fdanews.com/articles/209753-gestalt-diagnostics-gains-two-ce-ivd-marks
Gestalt Diagnostics Gains Two CE-IVD Marks
October 12, 2022
Spokane, Wash.-based Gestalt Diagnostics has received CE-IVD marks for two main components of its PathFlow product, which digitizes laboratory slides, makes them viewable and automates the images into a pathology laboratory workflow.
PathFlow is a cloud-based digital pathology platform that can be customized with education and research modules to suit a facility’s needs.
The platform is designed to use every component necessary to streamline the workflow for pathologists in clinical, education and research laboratories, as well as healthcare facilities, the company said.